/Docs/calaqstn.pdfRead More

Status of FDA permission requirements for Blood Bank establishment use of electronic crossmatch as of November 18, 1999: Because 21 CFR 606.151 requires a serologic crossmatch those hospitals (all hospitals) who wish to use the electronic crossmatch must apply for a variance to 21 CFR 606.151 (as allowed by 21 CFR 640.120) to gain written...Read More

/Docs/ISBT128Nov99.pdfRead More

/docs/Part11videotape1099.PDFRead More

/docs/otssswsubmissionguidance.pdfRead More

http://www.fda.gov/cdrh/ode/126.htmlRead More

/docs/Linweldpart11wl.PDFRead More

/docs/QSITGUIDE1999.pdfRead More

/docs/GPSVcrumplerpresentation.PDFRead More

/docs/FDAFDLIOverviewSWonlyslides699.pdfRead More

http://www.fda.gov/cdrh/ode/2246.htmlRead More

/Docs/FDApresentationonPart11ANDClinicalTrialsSW.pdfRead More

/Docs/ORAPart11CPG.pdfRead More

http://www.fda.gov/cdrh/ode/2242.pdfRead More

/docs/LIMSclassificationCFR862-2100.pdfRead More

/Docs/faq011299motisepresentation.pdfRead More

http://www.fda.gov/cdrh/ode/100.htmlRead More

http://www.fda.gov/cdrh/ode/radcalibrators.pdfRead More

/docs/FDA-MRIguidance1998.pdfRead More

http://www.fda.gov/cdrh/ode/93.htmlRead More

/docs/510kQandA.pdfRead More

/Docs/FDAfoodcomputersystemguide.pdfRead More

http://www.fda.gov/cdrh/ode/powerpump.pdfRead More

/docs/PACsclassificationRevision.pdfRead More

FDA CDRH Office of Device Evaluation standards recognition statement for ” IEC 60601-1-4:1996, Medical electrical equipment – Part 1: General requirements For safety; 4. Collateral Standard: Programmable electrical medical systems”. FDA did not choose to recognize this standard for software submissions or even outright for risk management. They did issue a recognition statement explaining their...Read More

/docs/HEMODIALYSISDELIVERYSYSTEMS.pdfRead More

/docs/washerdisinfectors1998draft.pdfRead More

http://www.fda.gov/cdrh/ode/73.htmlRead More

http://www.fda.gov/cdrh/ode/77.htmlRead More

http://www.fda.gov/cdrh/ode/75.htmlRead More

http://www.fda.gov/cdrh/ode/72.htmlRead More

http://www.fda.gov/cdrh/ode/74.htmlRead More

/Docs/CBERnew510kparadigmslides4perpage.pdfRead More

http://www.fda.gov/cdrh/devadvice/Read More

/docs/FDASoftwareSubmissionGuidance052898obsolete.pdfRead More

/docs/PACsclassification.pdfRead More

/docs/510knewparadigmguidance.pdfRead More

http://www.fda.gov/cdrh/ode/bgsguide.pdfRead More

http://www.fda.gov/cdrh/modact/daypmasp.pdfRead More

http://www.fda.gov/cdrh/manual/pmamanul.pdfRead More

http://www.fda.gov/cdrh/ode/eedev.htmlRead More

http://www.fda.gov/cdrh/ode/fetal.htmlRead More

/Docs/designcontrolguidance.pdfRead More

/docs/FDACorrections-removals.pdfRead More

/Docs/esignatureswithpreamble.pdfRead More

http://www.fda.gov/cdrh/ode/noninvas.htmlRead More

/Docs/PortableGlucoseSubmissionGuidance.htmRead More

http://www.fda.gov/cdrh/ode/83.htmlRead More

/Docs/Bloodbank510kguidance.pdfRead More

/docs/510kmod.pdfRead More